Price T Rowe Associates Inc Accolade, Inc. Transaction History
Price T Rowe Associates Inc
- $836 Billion
- Q2 2024
A detailed history of Price T Rowe Associates Inc transactions in Accolade, Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 23,691 shares of ACCD stock, worth $99,739. This represents 0.0% of its overall portfolio holdings.
Number of Shares
23,691
Previous 19,540
21.24%
Holding current value
$99,739
Previous $205,000
58.54%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding ACCD
# of Institutions
168Shares Held
66.3MCall Options Held
61KPut Options Held
566K-
Black Rock Inc. New York, NY6.16MShares$25.9 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl5.64MShares$23.8 Million0.18% of portfolio
-
Brown Advisory Inc5.45MShares$23 Million0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.12MShares$17.3 Million0.0% of portfolio
-
Ah Equity Partners Iv (Parallel), L.L.C. Menlo Park, CA3.78MShares$15.9 Million88.81% of portfolio
About Accolade, Inc.
- Ticker ACCD
- Exchange NASDAQ
- Sector Healthcare
- Industry Health Information Services
- Shares Outstandng 71,938,896
- Market Cap $303M
- Description
- Accolade, Inc., together with its subsidiaries, develops and provides technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based technology and multimodal support from a team of health assistants and cli...